Temsamani F, Agalit A, Idrissi Serhrouchni K
Cureus. 2025; 17(1):e77362.
PMID: 39944459
PMC: 11815987.
DOI: 10.7759/cureus.77362.
Smith L, Quelch-Cliffe R, Liu F, Aguilar A, Przyborski S
Stem Cell Rev Rep. 2024; 21(1):107-125.
PMID: 39340737
PMC: 11762643.
DOI: 10.1007/s12015-024-10793-5.
Isasi R, Bentzen H, Fabbri M, Fuhr A, Glover J, Mah N
Stem Cell Reports. 2024; 19(9):1233-1241.
PMID: 39151430
PMC: 11411296.
DOI: 10.1016/j.stemcr.2024.07.006.
Terheyden-Keighley D, Huhne M, Berger T, Hiller B, Martins S, Gamerschlag A
Stem Cells Transl Med. 2024; 13(9):898-911.
PMID: 39042522
PMC: 11386223.
DOI: 10.1093/stcltm/szae047.
Kuebler B, Alvarez-Palomo B, Aran B, Castano J, Rodriguez L, Raya A
Stem Cell Res Ther. 2023; 14(1):366.
PMID: 38093328
PMC: 10720139.
DOI: 10.1186/s13287-023-03576-1.
Country-specific regulation and international standardization of cell-based therapeutic products derived from pluripotent stem cells.
Hirai T, Yasuda S, Umezawa A, Sato Y
Stem Cell Reports. 2023; 18(8):1573-1591.
PMID: 37557074
PMC: 10444560.
DOI: 10.1016/j.stemcr.2023.05.003.
Application-Oriented Bulk Cryopreservation of Human iPSCs in Cryo Bags Followed by Direct Inoculation in Scalable Suspension Bioreactors for Expansion and Neural Differentiation.
Meiser I, Alstrup M, Khalesi E, Stephan B, Speicher A, Majer J
Cells. 2023; 12(14).
PMID: 37508576
PMC: 10378238.
DOI: 10.3390/cells12141914.
In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells.
Pridgeon C, Forootan S, Zhang F, Harper N, Palmer D, Weightmann R
J Stem Cells Regen Med. 2023; 19(1):3-13.
PMID: 37366409
PMC: 10290816.
DOI: 10.46582/jsrm.1901002.
Efficient derivation and banking of clinical-grade human embryonic stem cell lines in accordance with Japanese regulations.
Takada K, Nakatani R, Moribe E, Yamazaki-Fujigaki S, Fujii M, Furuta M
Regen Ther. 2022; 21:553-559.
PMID: 36397823
PMC: 9647332.
DOI: 10.1016/j.reth.2022.10.006.
Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies.
Kim J, Kawase E, Bharti K, Karnieli O, Arakawa Y, Stacey G
NPJ Regen Med. 2022; 7(1):54.
PMID: 36175440
PMC: 9522845.
DOI: 10.1038/s41536-022-00242-7.
Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications.
Abberton K, McDonald T, Diviney M, Holdsworth R, Leslie S, Delatycki M
Stem Cells Transl Med. 2022; 11(10):1052-1060.
PMID: 36073721
PMC: 9585951.
DOI: 10.1093/stcltm/szac060.
Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells.
Alvarez-Palomo B, Veiga A, Raya A, Codinach M, Torrents S, Ponce Verdugo L
Stem Cell Res Ther. 2022; 13(1):408.
PMID: 35962457
PMC: 9372949.
DOI: 10.1186/s13287-022-02961-6.
Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development.
Stacey G, Cao J, Hu B, Zhou Q
Cell Prolif. 2022; 55(8):e13301.
PMID: 35933704
PMC: 9357356.
DOI: 10.1111/cpr.13301.
Biobanking of human pluripotent stem cells in China.
Stacey G, Hao J
Cell Prolif. 2022; 55(7):e13180.
PMID: 35652319
PMC: 9251045.
DOI: 10.1111/cpr.13180.
Advances in hPSC expansion towards therapeutic entities: A review.
Tannenbaum S, Reubinoff B
Cell Prolif. 2022; 55(8):e13247.
PMID: 35638399
PMC: 9357360.
DOI: 10.1111/cpr.13247.
Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration.
Dehghan S, Mirshahi R, Shoae-Hassani A, Naseripour M
Stem Cell Res Ther. 2022; 13(1):217.
PMID: 35619143
PMC: 9137077.
DOI: 10.1186/s13287-022-02894-0.
Principles and Protocols For Post-Cryopreservation Quality Evaluation of Stem Cells in Novel Biomedicine.
Xie J, Ekpo M, Xiao J, Zhao H, Bai X, Liang Y
Front Pharmacol. 2022; 13:907943.
PMID: 35592426
PMC: 9113563.
DOI: 10.3389/fphar.2022.907943.
Manufacturing clinical-grade human induced pluripotent stem cell-derived beta cells for diabetes treatment.
Tan L, Chen J, Lim L, Teo A
Cell Prolif. 2022; 55(8):e13232.
PMID: 35474596
PMC: 9357357.
DOI: 10.1111/cpr.13232.
Developing standards to support cell technology applications.
Cao J, Stacey G, Shyh-Chang N, Zhao T
Cell Prolif. 2022; 55(4):e13210.
PMID: 35274782
PMC: 9055890.
DOI: 10.1111/cpr.13210.
Translating stem cell research into development of cellular drugs-a perspective from manufacture of stem cell products and CMC considerations.
Zhang Y, Stacey G
Cell Prolif. 2022; 55(8):e13203.
PMID: 35165957
PMC: 9357354.
DOI: 10.1111/cpr.13203.
